MediSapiens Inc. is ramping up its U.S. operations with plans to open a new office in the Cambridge Innovation Center incubator at One Broadway in Cambridge’s Kendall Square by the end of the year.

MediSapiens, a subsidiary of a Finland-based bioinformatics company, develops bioinformatics software for visualization of biologic datasets for the pharmaceutical industry and academia.

Company President Rami Kokonen said Massachusetts was the "clear choice" for its first U.S. office.

"There simply is no match for it when it comes to the concentration of pharma industry and health technology," Kokonen said in a statement.

The company has been occupying short-term space at 245 First St. in Cambridge since September 2013.

Owned by the Massachusetts Institute of Technology, the 16-story One Broadway building contains 312,704 square feet of office and lab space including the Cambridge Innovation Center, a 150,000-square-foot incubator for tech startups.